Weight loss drugs like Ozempic and Wegovy are already transforming lives – but could their impact on the economy be even bigger?

Liam Dann and Tamsyn Parker look at predictions GLP-1 drugs could boost the US economy by hundreds of billions of dollars, slash healthcare costs and fundamentally change the food industry.

And could New Zealand be one of the big winners as demand shifts towards protein?

Plus, they break down the latest OCR decision, why different parts of New Zealand arguably need very different interest rates, and what to expect from the next GDP figures.